CSE:ACOG - Post Discussion
Post by
partystocker on Dec 05, 2021 4:16pm
$ACOG appoints new CMO
Alpha Cognition $ACOG/$ACOG.V has appointed Cedric O’Gorman as their chief medical officer. Gorman will lead medical, clinical and regulatory functions in support of the company’s clinical-stage products.
O’Gorman has more than 20 years of experience in clinical development, medical affairs and medical strategy. O’Gorman has worked in senior roles at many companies, including Axsome Therapeutics, Intra-Cellular Therapies, Genentech/Roche and Pfizer.
This looks like a solid addition to the company's leadership. I’m really hoping we can get news of progress regarding the company's drugs and therapies in development. Shares have been on a 40% decline since September, which has me watching for signs of a reversal.
Currently, shares of $ACOG are trading at $1.13 and the company is valued at $69 million.
https://ceo.ca/@businesswire/alpha-cognition-appoints-cedric-ogorman-md-mba
Be the first to comment on this post